Infant Formula Price-Fixing Suit Jurisdiction Granted High Court Review
This article was originally published in The Tan Sheet
Executive Summary
The U.S. Supreme Court on Nov. 29 agreed to decide whether a Louisiana state court lawsuit alleging infant formula price-fixing was properly removed to federal court, where it was eventually dismissed. The high court's decision in Free v. Abbott Laboratories is expected by July.
You may also be interested in...
Federal Jurisdiction Of Formula Price-Fixing Suit Appropriate - Companies
The claims of absent class members in an infant formula price-fixing lawsuit are part of the same "case or controversy" as the named plaintiffs' claims over which a Louisiana federal court had jurisdiction to dismiss, Abbott Labs and Bristol-Myers Squibb tell the U.S. Supreme Court.
Federal Jurisdiction Of Formula Price-Fixing Suit Appropriate - Companies
The claims of absent class members in an infant formula price-fixing lawsuit are part of the same "case or controversy" as the named plaintiffs' claims over which a Louisiana federal court had jurisdiction to dismiss, Abbott Labs and Bristol-Myers Squibb tell the U.S. Supreme Court.
Federal Jurisdiction Of Formula Price-Fixing Suit Appropriate - Companies
The claims of absent class members in an infant formula price-fixing lawsuit are part of the same "case or controversy" as the named plaintiffs' claims over which a Louisiana federal court had jurisdiction to dismiss, Abbott Labs and Bristol-Myers Squibb tell the U.S. Supreme Court.